LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 213 filers reported holding LOXO ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $22,623,406,000 | -18.3% | 161,515 | -0.4% | 0.02% | -9.5% |
| Q3 2018 | $27,702,135,000 | -12.5% | 162,162 | -11.2% | 0.02% | -12.5% |
| Q2 2018 | $31,662,528,000 | +37.8% | 182,514 | -8.4% | 0.02% | +33.3% |
| Q1 2018 | $22,982,627,000 | +29.2% | 199,208 | -5.7% | 0.02% | +20.0% |
| Q4 2017 | $17,781,679,000 | -6.8% | 211,234 | +2.0% | 0.02% | -11.8% |
| Q3 2017 | $19,072,618,000 | -1.0% | 207,041 | -13.9% | 0.02% | -10.5% |
| Q2 2017 | $19,272,704,000 | +159.3% | 240,338 | +36.0% | 0.02% | +137.5% |
| Q1 2017 | $7,433,853,000 | +107077.8% | 176,660 | -18.2% | 0.01% | 0.0% |
| Q4 2016 | $6,936,000 | +14.9% | 215,956 | -6.3% | 0.01% | +33.3% |
| Q3 2016 | $6,037,000 | +24.6% | 230,575 | +10.3% | 0.01% | +20.0% |
| Q2 2016 | $4,847,000 | +120.6% | 209,098 | +160.3% | 0.01% | +66.7% |
| Q1 2016 | $2,197,000 | – | 80,344 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,438,920 | $289,488,000 | 57.19% |
| DAFNA Capital Management LLC | 296,000 | $24,917,000 | 13.42% |
| Casdin Capital, LLC | 360,000 | $30,305,000 | 7.38% |
| Opaleye Management Inc. | 176,300 | $14,841,000 | 4.75% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 574,495 | $48,361,000 | 1.84% |
| SECTORAL ASSET MANAGEMENT INC | 152,185 | $12,811,000 | 1.60% |
| AWM Investment Company, Inc. | 85,000 | $7,155,000 | 1.39% |
| Eventide Asset Management | 285,000 | $23,991,000 | 1.25% |
| Rock Springs Capital Management LP | 310,000 | $26,096,000 | 1.18% |
| Crawford Lake Capital Management, LLC | 53,420 | $4,497,000 | 1.06% |